United Kingdom

Coronavirus Drug and Treatment Tracker--New York Times

Submitted by mike kraft on Tue, 2020-07-21 11:24

Coronavirus Drug and Treatment Tracker An updated list of potential treatments for Covid-19. nytimes

Below is an updated list of 19 of the most-talked-about treatments for the coronavirus. While some are accumulating evidence that they’re effective, most are still at early stages of research. We also included a warning about a few that are just bunk....

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Solutions

Situation Report

Read more about Coronavirus Drug and Treatment Tracker--New York Times
Log in or register to post comments

While the latest research suggests that antibodies against Covid-19 could be lost in just three months, a new hope has appeared on the horizon: the enigmatic T cell.

Submitted by mike kraft on Mon, 2020-07-20 17:13

The people with hidden immunity against Covid-19 While the latest research suggests that antibodies against Covid-19 could be lost in just three months, a new hope has appeared on the horizon: the enigmatic T cell. Zaria Gorvett BBC_Future

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Solutions

Situation Report

ANALYSIS: How America’fumbled its response to the coronavirus

Submitted by mike kraft on Mon, 2020-07-20 13:51

The crisis that shocked the world: America’s response to the coronavirus How the world’s richest country got into this dismal situation is a complicated tale that exposes the flaws and fissures in a nation long proud of its ability to meet cataclysmic challenges. Joel Achenbach, William Wan, Karin Brulliard, Chelsea Janes Washington Post

....

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Problem

Situation Report

Read more about ANALYSIS: How America’fumbled its response to the coronavirus
Log in or register to post comments

Studies provide glimpse at efficacy of Covid-19 vaccines from Oxford-AstraZeneca and CanSino

Submitted by mike kraft on Mon, 2020-07-20 12:20

New data offer glimpse of efficacy of Oxford-AstraZeneca Covid-19 vaccine The vaccine generated an immune response in a study of roughly 1,000 patients, and all of the side effects were deemed mild or moderate. Matthew Herper STAT

A Covid-19 vaccine being developed by Oxford University and the drug giant AstraZeneca generated an immune response in a study of roughly 1,000 patients, according to interim results published Monday.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Solutions

Situation Report

Read more about Studies provide glimpse at efficacy of Covid-19 vaccines from Oxford-AstraZeneca and CanSino
Log in or register to post comments

Worldwide: Tracking the spread of the novel coronavirus

Submitted by mike kraft on Mon, 2020-07-20 09:22

Tracking the spread of the novel coronavirus Reuters maps all places where COVID-19 cases have been confirmed. Gurman Bhatia Reuters

At least 605,782 people globally have died from COVID-19 and 14,576,899 have been infected by the novel coronavirus that causes it, following an outbreak that started in Wuhan, China, in early December. The World Health Organization referred to it as a pandemic on March 11, 2020.

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Worldwide: Tracking the spread of the novel coronavirus
Log in or register to post comments

Superspreading’ events, triggered by people who may not even know they are infected, propel coronavirus pandemic

Submitted by mike kraft on Sun, 2020-07-19 11:55

‘Superspreading’ events, triggered by people who may not even know they are infected, propel coronavirus pandemic Most spread the virus to only a few people — or none at all. But a small percentage transmit it with alarming efficiency, studies show. Ariana Eunjung Cha Washington Post

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Problem

Situation Report

Older Children Spread the Coronavirus Just as Much as Adults, Large Study Finds

Submitted by mike kraft on Sat, 2020-07-18 18:15

The study of nearly 65,000 people in South Korea suggests that school reopenings will trigger more outbreaks.

-0-

In the heated debate over reopening schools, one burning question has been whether and how efficiently children can spread the virus to others.

A large new study from South Korea offers an answer: Children younger than 10 transmit to others much less often than adults do, but the risk is not zero. And those between the ages of 10 and 19 can spread the virus at least as well as adults do.

The findings suggest that as schools reopen, communities will see clusters of infection take root that include children of all ages, several experts cautioned.

“I fear that there has been this sense that kids just won’t get infected or don’t get infected in the same way as adults and that, therefore, they’re almost like a bubbled population,” said Michael Osterholm, an infectious diseases expert at the University of Minnesota....

Country / Region Tags: